Akso Health (AHG) Receivables - Other (2017 - 2026)

Akso Health (AHG) has reported Receivables - Other for 7 consecutive years, with $184.8 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Other fell 8.82% year-over-year to $184.8 million; the trailing twelve-month figure through Mar 2026 stood at $184.8 million (down 8.82% YoY), and the FY2026 full-year result was $184.8 million, down 8.82% from the prior year.
• Receivables - Other fell to $184.8 million in Q1 2026 per AHG's latest filing, from $202.6 million in the prior quarter.
• Across five years, Receivables - Other topped out at $202.6 million in Q1 2025 and bottomed at $1.5 million in Q1 2023.
• Historically, Receivables - Other has averaged $86.9 million across 4 years, with a median of $25.4 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Receivables - Other soared 463.1% in 2022, then plunged 92.36% in 2023.
• Over 4 years, Receivables - Other stood at $25.4 million in 2022, then tumbled by 93.97% to $1.5 million in 2023, then surged by 13153.02% to $202.6 million in 2025, then slipped by 8.82% to $184.8 million in 2026.
• According to Business Quant data, Receivables - Other over the past three periods registered $184.8 million, $202.6 million, and $1.5 million for Q1 2026, Q1 2025, and Q1 2023 respectively.